Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Kenneth Gordon
When Family Law Crosses International Borders
Kenneth A. Gordon of Brinkley Morgan. Courtesy photo For many Americans, moving abroad once sounded like something reserved for retirement or an adventurous chapter later in life. That is changing as remote work, international business opportunities, family connections, and the appeal of a different lifestyle have made living overseas increasingly realistic for professionals and families.
Whooping cough is on the rise in Virginia. Here's what you need to know. | Kenneth Gordon
Pertussis, also known as whooping cough or the 100-day cough, is a highly contagious bacterial disease caused by the bacterium Bordetella pertussis that occurs only in humans. k2D:56 4=2DDlQE?4>D\:?=:?6\C6=4@?E6?E E?4>D\:?=:?6\C6=4@?E6?E\724E E?4>D\:?=:?6\2=:8?>6?E\C:89EQmk9cm':E2= $:8?Dk^9cmkAm%9:D 4@=F>?[ H9:49 AC@>@E6D 4@>>F?:EJ 962=E9[ :D DA@?D@C65 3J $6?E2C2 |2CE92 y6776CD@? w@DA:E2=[ #68:@? %6?
Kenneth Gordon: Vaccination is our best defense against measles
Measles, or rubeola, is a viral disease that causes fever and rash. Before the vaccine was available, an estimated 48,000 people were hospitalized and 400 to 500 people died from measles in the United States each year. Measles is not a seasonal virus, but it often spreads during times of high travel, including spring break, or in situations where unvaccinated persons are in close quarters, such as summer camp.
Bimekizumab for the treatment of psoriasis
M Thapar – none; M Patel – none, K Gordon – has received honoraria or research support from the following pharmaceutical companies: Abbvie, Arcutis, Amgen, BMS, Boerhinger Ingelheim, Dermavant, DICE, Eli Lilly, Incyte, Janssen, Leo, MoonLake, Novartis, Pfizer, Protagonist, UCB, Union.
Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary
Key Points Question What constituted meaningful within-patient score improvement on the Psoriasis Symptoms and Signs Diary (PSSD) in a phase 3 trial among patients with psoriasis?
Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis – Authors' reply
Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis – Authors' reply - The Lancet Rheumatology
Tick-borne illness prevention requires vigilance and preparation
Did you know Virginia is home to 16 native tick species? Of these, the Lone Star, Blacklegged (a.k.a. deer tick) and American Dog tick are the three species most known to bite humans. This is important because they carry several diseases including Lyme disease, anaplasmosis, babesiosis, Borrelia miyamotoi disease, and tickborne encephalitis virus.
The Rest of the Iceberg: The Hidden Costs of Divorce
From Data to Decisions Dynamically explore and compare data on law firms, companies, individual lawyers, and industry trends. Exclusive Depth and Reach. Law.com Compass includes access to our exclusive industry reports, combining the unmatched expertise of our analyst team with ALM’s deep bench of proprietary information to provide insights that can’t be found anywhere else.
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
Psoriasis
Financial Disclosures Dr. Gordon has received honoraria or research support from the following pharmaceutical companies: Abbvie, Almirall, Amgen, BMS, Dermavant, Dermira, Eli Lilly, Jannsen, Kyowa Hakko Kirin, Leo, Novartis, Pfizer, Sun, UCB, Union Source: Content for this module was reproduced with permission from: Ruderman EM, Gordon KB. Clinical Management of Psoriatic Arthritis and Psoriasis. 4th ed. Professional Communications Inc. 2022. All rights reserved.
Psoriatic Arthritis
Financial Disclosures Dr. Gordon has received honoraria or research support from the following pharmaceutical companies: Abbvie, Almirall, Amgen, BMS, Dermavant, Dermira, Eli Lilly, Jannsen, Kyowa Hakko Kirin, Leo, Novartis, Pfizer, Sun, UCB, Union. Source: Content for this module was reproduced with permission from: Ruderman EM, Gordon KB. Clinical Management of Psoriatic Arthritis and Psoriasis. 4th ed. Professional Communications Inc. 2022. All rights reserved.
Topical Therapy for Psoriasis
Introduction Treatment of psoriasis with topical medication is the first line of therapy for almost all psoriasis patients. Although psoriasis is a disease of systemic immune activity, the clinical manifestations are local to the skin. As the plaques are visible and accessible for application of topical medications, it makes intuitive sense to deliver treatment directly.
Primary Care Physician Guide to Psoriatic Disease
More in Primary Care Physician Guide to Psoriatic Disease Introduction Psoriasis is a very common condition that affects 2% to 3% of the general population worldwide, with more than 7 million individuals in the United States living with the disease. Approximately 30% of patients with psoriasis will develop PsA. Therefore, a primary care physician (PCP) has a good chance of encountering patients with psoriasis and PsA in their practice.
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials | Dermatology | JAMA Dermatology | JAMA Network [Skip to Navigation] Figure 1.
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
Summary Background Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A. This study investigated the efficacy and safety of bimekizumab in patients with moderate to severe plaque psoriasis, the effects of treatment withdrawal, and two maintenance dosing schedules over 56 weeks.
Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis
Key Points Question What are the patient-reported outcomes of risankizumab treatment for moderate to severe chronic plaque psoriasis in UltIMMa-1 and UltIMMa-2?
Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary: A Secondary Analysis of a Randomized Clinical Trial
Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary: A Secondary Analysis of a Randomized Clinical Trial Autores: Kim A. Papp, Kenneth B. Gordon, Bruce E. Strober, Joe Zhuo, Brandon Becker, Yichen Zhong, Jennifer L. Beaumont, Tan P. Pham, Renata Kisa, Andrew A. Napoli, Subhashis Banerjee, April W. Armstrong Localización: JAMA Dermatology, ISSN 2168-6068, Vol. 160, Nº. 2, 2024, págs.
How to Maintain Balance While Working from Home
Last year, 43 percent of employed Americans spent some time working from home, and studies show that the practice has done some good: Work-from-home warriors are more productive and generally report that they’re happier at work. But, of course, there are some downsides. When your work is at home, it can often feel like it’s impossible to escape, and the lines between work life and home life become increasingly blurred.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Kenneth
Contact Kenneth, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack